Boston Common Asset Management’s Boston Scientific BSX Stock Holding History

Boston Common Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,127	Closed	-$237K	–	306
2022 Q4	$237K	Buy	+5,127	New	+$222K	0.01%	248
2022 Q1	–	Sell	-5,004	Closed	-$213K	–	267
2021 Q4	$213K	Buy	5,004 +274	+6%	+$11.5K	0.01%	257
2021 Q3	$205K	Buy	4,730 +38	+0.8%	+$1.68K	0.01%	249
2021 Q2	$201K	Buy	+4,692	New	+$197K	0.01%	252

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Common Asset Management's BSX Position: Q1 2023 in Review

Boston Common Asset Management sold out of Boston Scientific (BSX) in Q1 2023, closing a stake of 5,127 shares — an estimated $237K sold.

Boston Common Asset Management first reported a position in BSX in Q2 2021 and held it in 4 quarters. The position peaked at $237K in Q4 2022. 996 funds tracked by Wall St. Rank hold BSX as of Q1 2023.

Boston Common Asset Management reported no remaining Boston Scientific position as of Q1 2023 after selling out during the quarter.
Boston Common Asset Management sold 5,127 Boston Scientific shares in Q1 2023, an estimated $237K.
Boston Common Asset Management first reported a position in Boston Scientific in Q2 2021 and held it in 4 quarters.
Boston Common Asset Management's Boston Scientific position peaked at $237K in Q4 2022.
996 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2023.

Based on Boston Common Asset Management's 13F filing for Q1 2023, filed 17 May 2023.